PD-1 regulates extrathymic regulatory T-cell differentiation

European Journal of Immunology

Volumn 44, Issue 9, 2014, Pages 2603-2616

  Chen, Xiufen ^a   Fosco, Dominick ^a   Kline, Douglas E ^a   Meng, Liping ^a   Nishi, Saki ^a   Savage, Peter A ^a   Kline, Justin ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

PD 1; Treg cell; Treg cell development; Treg cell differentiation; Treg cell function

Indexed keywords

PDCD1 PROTEIN, MOUSE; PROGRAMMED DEATH 1 RECEPTOR;

ANIMAL; ARTICLE; CELL DIFFERENTIATION; CYTOLOGY; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; KNOCKOUT MOUSE; MOUSE; PD-1; PHYSIOLOGY; REGULATORY T LYMPHOCYTE; THYMUS; TREG CELL; TREG-CELL DEVELOPMENT; TREG-CELL DIFFERENTIATION; TREG-CELL FUNCTION;

PD-1; TREG CELL; TREG-CELL DEVELOPMENT; TREG-CELL DIFFERENTIATION; TREG-CELL FUNCTION;

ANIMALS; CELL DIFFERENTIATION; IMMUNE TOLERANCE; MICE; MICE, KNOCKOUT; PROGRAMMED CELL DEATH 1 RECEPTOR; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND;

EID: 84907810196     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201344423     Document Type: Article

References (56)

1. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. and Toda, M., Immunologic self-tolerancemaintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of selftolerance causes various autoimmune diseases. J. Immunol. 1995. 155: 1151-1164.
2. Sakaguchi, S., Yamaguchi, T., Nomura, T. and Ono,M., Regulatory T cells and immune tolerance. Cell 2008. 133: 775-787.
3. Workman, C. J., Szymczak-Workman, A. L., Collison, L. W., Pillai, M. R. and Vignali, D. A., The development and function of regulatory T cells. Cell. Mol. Life Sci. 2009. 66: 2603-2622.
4. Hori, S., Nomura, T. and Sakaguchi, S., Control of regulatory T cell development by the transcription factor Foxp3. Science 2003. 299: 1057-1061.
5. Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E. et al., The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused bymutations of FOXP3. Nat. Genet. 2001. 27: 20-21.
6. Brunkow, M. E., Jeffery, E. W., Hjerrild, K. A., Paeper, B., Clark, L. B., Yasayko, S. A., Wilkinson, J. E. et al., Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 2001. 27: 68-73.
7. Chen,W., Jin, W., Hardegen, N., Lei, K. J., Li, L., Marinos, N., McGrady, G. et al., Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 2003. 198: 1875-1886.
8. Mucida, D., Kutchukhidze, N., Erazo, A., Russo, M., Lafaille, J. J. and Curotto de Lafaille, M. A., Oral tolerance in the absence of naturally occurring Tregs. J. Clin. Invest. 2005. 115: 1923-1933.
9. Sun, C. M., Hall, J. A., Blank, R. B., Bouladoux, N., Oukka, M., Mora, J. R. and Belkaid, Y., Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 2007. 204: 1775-1785.
10. Hadis, U., Wahl, B., Schulz, O., Hardtke-Wolenski, M., Schippers, A., Wagner, N., Muller, W. et al., Intestinal tolerance requires gut homing and expansion of FoxP3+ regulatory T cells in the lamina propria. Immunity 2011. 34: 237-246.
11. Curotto de Lafaille, M. A., Kutchukhidze, N., Shen, S., Ding, Y., Yee, H. and Lafaille, J. J., Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation. Immunity 2008. 29: 114- 126.
12. Cao, X., Regulatory T cells and immune tolerance to tumors. Immunol. Res. 2010. 46: 79-93.
13. Elpek, K. G., Lacelle, C., Singh, N. P., Yolcu, E. S. and Shirwan, H., CD4+CD25+ T regulatory cells dominate multiple immune evasion mechanisms in early but not late phases of tumor development in a B cell lymphoma model. J. Immunol. 2007. 178: 6840-6848.
14. Francisco, L. M., Sage, P. T. and Sharpe, A. H., The PD-1 pathway in tolerance and autoimmunity. Immunol. Rev. 2010. 236: 219-242.
15. Ishida, Y., Agata, Y., Shibahara, K. and Honjo, T., Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 1992. 11: 3887-3895.
16. Keir, M. E., Francisco, L. M. and Sharpe, A. H., PD-1 and its ligands in T-cell immunity. Curr. Opin. Immunol. 2007. 19: 309-314.
17. Dong, H., Zhu, G., Tamada, K. and Chen, L., B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 1999. 5: 1365-1369.
18. Yamazaki, T., Akiba, H., Iwai, H., Matsuda, H., Aoki, M., Tanno, Y., Shin, T. et al., Expression of programmed death 1 ligands by murine T cells and APC. J. Immunol. 2002. 169: 5538-5545.
19. Zhang, Y., Chung, Y., Bishop, C., Daugherty, B., Chute, H., Holst, P., Kurahara, C. et al., Regulation of T cell activation and tolerance by PDL2. Proc. Natl. Acad. Sci. USA 2006. 103: 11695-11700.
20. Nishimura, H., Nose, M., Hiai, H., Minato, N. and Honjo, T., Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999. 11: 141-151.
21. Okazaki, T. and Honjo, T., The PD-1-PD-L pathway in immunological tolerance. Trends Immunol. 2006. 27: 195-201.
22. Riley, J. L., PD-1 signaling in primary T cells. Immunol. Rev. 2009. 229:114-125.
23. Okazaki, T., Tanaka, Y., Nishio, R., Mitsuiye, T., Mizoguchi, A., Wang, J., Ishida, M. et al., Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nat. Med. 2003. 9: 1477-1483.
24. Blank, C., Gajewski, T. F. and Mackensen, A., Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy. Cancer Immunol. Immunother. 2005. 54: 307-314.
25. Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C. et al., Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 2002. 8: 793-800.
26. Curiel, T. J., Wei, S., Dong, H., Alvarez, X., Cheng, P., Mottram, P., Krzysiek, R. et al., Blockade of B7-H1 improves myeloid dendritic cellmediated antitumor immunity. Nat. Med. 2003. 9: 562-567.
27. Liang, S. C., Latchman, Y. E., Buhlmann, J. E., Tomczak, M. F., Horwitz, B. H., Freeman, G. J. and Sharpe, A. H., Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur. J. Immunol. 2003. 33: 2706-2716.
28. Brahmer, J. R., Tykodi, S. S., Chow, L. Q., Hwu, W. J., Topalian, S. L., Hwu, P., Drake, C. G. et al., Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N. Engl. J. Med. 2012. 366: 2455-2465.
29. Thompson, R. H., Gillett, M. D., Cheville, J. C., Lohse, C. M., Dong, H., Webster, W. S., Krejci, K. G. et al., Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target. Proc. Natl. Acad. Sci. USA 2004. 101: 17174-17179.
30. Zhang, L., Gajewski, T. F. and Kline, J., PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model. Blood 2009. 114: 1545-1552.
31. Hirano, F., Kaneko, K., Tamura, H., Dong, H., Wang, S., Ichikawa, M., Rietz, C. et al., Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity. Cancer Res. 2005. 65: 1089-1096.
32. Wang, L., Pino-Lagos, K., de Vries, V. C., Guleria, I., Sayegh, M. H. and Noelle, R. J., Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells. Proc. Natl. Acad. Sci. USA 2008. 105: 9331-9336.
33. Francisco, L. M., Salinas, V. H., Brown, K. E., Vanguri, V. K., Freeman, G. J., Kuchroo, V. K. and Sharpe, A. H., PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J. Exp. Med. 2009. 206: 3015-3029.
34. Zhou, Q., Munger, M. E., Highfill, S. L., Tolar, J., Weigel, B. J., Riddle, M., Sharpe, A. H. et al., Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia. Blood 2010. 116: 2484- 2493.
35. Keir, M. E., Butte, M. J., Freeman, G. J. and Sharpe, A. H., PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 2008. 26: 677-704.
36. Raimondi, G., Shufesky, W. J., Tokita, D., Morelli, A. E. and Thomson, A. W., Regulated compartmentalization of programmed cell death-1 discriminates CD4+CD25+ resting regulatory T cells from activated T cells. J. Immunol. 2006. 176: 2808-2816.
37. Fontenot, J. D., Gavin, M. A. and Rudensky, A. Y., Foxp3 programs the development and function of CD4+CD25 +regulatory T cells. Nat. Immunol. 2003. 4: 330-336.
38. Thornton, A. M., Korty, P. E., Tran, D. Q., Wohlfert, E. A., Murray, P. E., Belkaid, Y. and Shevach, E. M., Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J. Immunol. 2010. 184: 3433-3441.
39. Kronenberg, M. and Rudensky, A., Regulation of immunity by selfreactive T cells. Nature 2005. 435: 598-604.
40. Jordan, M. S., Boesteanu, A., Reed, A. J., Petrone, A. L., Holenbeck, A. E., Lerman, M. A., Naji, A. et al., Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2001. 2: 301-306.
41. Malchow, S., Leventhal, D. S., Nishi, S., Fischer, B. I., Shen, L., Paner, G. P., Amit, A. S. et al., Aire-dependent thymic development of tumorassociated regulatory T cells. Science 2013. 339: 1219-1224.
42. Workman, C. J., Collison, L. W., Bettini, M., Pillai, M. R., Rehg, J. E. and Vignali, D. A., In vivo Treg suppression assays. Methods Mol. Biol. 2011. 707: 119-156.
43. Curotto de Lafaille, M. A., Lino, A. C., Kutchukhidze, N. and Lafaille, J. J., CD25- T cells generate CD25+Foxp3 +regulatory T cells by peripheral expansion. J. Immunol. 2004. 173: 7259-7268.
44. Zhang, X., Izikson, L., Liu, L. and Weiner, H. L., Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration. J. Immunol. 2001. 167: 4245-4253.
45. Hauet-Broere, F., Unger, W. W., Garssen, J., Hoijer, M. A., Kraal, G. and Samsom, J. N., Functional CD25- and CD25 +mucosal regulatory T cells are induced in gut-draining lymphoid tissue within 48h after oral antigen application. Eur. J. Immunol. 2003. 33: 2801-2810.
46. Pabst, O. and Bernhardt, G., On the road to tolerance-generation and migration of gut regulatory T cells. Eur. J. Immunol. 2013. 43: 1422-1425.
47. Haribhai, D., Williams, J. B., Jia, S., Nickerson, D., Schmitt, E. G., Edwards, B., Ziegelbauer, J. et al., A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity. Immunity 2011. 35: 109-122.
48. Akimova, T., Beier, U. H., Wang, L., Levine, M. H. and Hancock, W. W., Helios expression is a marker of T cell activation and proliferation. PLoS One 2011. 6: e24226.
49. Serre, K., Benezech, C., Desanti, G., Bobat, S., Toellner, K. M., Bird, R., Chan, S. et al., Helios is associated with CD4 T cells differentiating to T helper 2 and follicular helper T cells in vivo independently of Foxp3 expression. PLoS One 2011. 6: e20731.
50. Moran, A. E., Holzapfel, K. L., Xing, Y., Cunningham, N. R., Maltzman, J. S., Punt, J. and Hogquist, K. A., T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse. J. Exp. Med. 2011. 208: 1279-1289.
51. Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G. and Rudensky, A. Y., Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005. 22: 329-341.
52. Bettini, M. L., Pan, F., Bettini, M., Finkelstein, D., Rehg, J. E., Floess, S., Bell, B. D. et al., Loss of epigenetic modification driven by the Foxp3 transcription factor leads to regulatory T cell insufficiency. Immunity 2012. 36: 717-730.
53. Darce, J., Rudra, D., Li, L., Nishio, J., Cipolletta, D., Rudensky, A. Y., Mathis, D. et al., An N-terminal mutation of the Foxp3 transcription factor alleviates arthritis but exacerbates diabetes. Immunity 2012. 36: 731-741.
54. Molinero, L. L., Miller, M. L., Evaristo, C. and Alegre, M. L., High TCR stimuli prevent induced regulatory T cell differentiation in a NF-kappaBdependent manner. J. Immunol. 2011. 186: 4609-4617.
55. Guo, X., Qiu, J., Tu, T., Yang, X., Deng, L., Anders, R. A., Zhou, L. et al., Induction of innate lymphoid cell-derived interleukin-22 by the transcription factor STAT3 mediates protection against intestinal infection. Immunity 2014. 40: 25-39.
56. Gingrich, J. R., Barrios, R. J., Morton, R. A., Boyce, B. F., DeMayo, F. J., Finegold, M. J., Angelopoulou, R. et al., Metastatic prostate cancer in a transgenic mouse. Cancer Res. 1996. 56: 4096-4102.